Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...

Layoffs are looming in Switzerland as Novartis announces its plans to cut upwards of 550 full-time positions by the end of ...

Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes ...

Cancerguard, a multi-cancer early detection blood test.

Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, continues his conversation about ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...

In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy for adolescents and adults with spinal muscular ...